Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estimation of Minimum Efficacy Daily Dose (MTDD) of Jarlsberg Cheese in Healthy Women in Order to Obtain Needed Level of Osteocalcin: A Phase I Dose-finding Study

NCT04185454 is registered in ClinicalTrials.gov with Prof Stig Larsen as lead sponsor.

NCT NCT04185454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04185454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estimation of Minimum Efficacy Daily Dose (MTDD) of Jarlsberg Cheese in Healthy Women in Order to Obtain Needed Level of Osteocalcin: A Phase I Dose-finding Study
Lead sponsor
Prof Stig Larsen
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2018
Completion date
April 15, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, diabetes, exlution criteria: gastrointestinal disorder, heathy women, kidney disorder, liver disease, pre menopausal age